Obesity drugs could bankrupt US healthcare, says Sanders
A report issued by the office of US Senator Bernie Sanders has claimed that the high prices being charged for new GLP-1 agonist-based obesity therapies like Novo Nordisk’s
Lung disease imaging AI from Brainomix gets FDA nod
Artificial intelligence company Brainomix has claimed FDA approval for e-Lung, which assists in the diagnosis and assessment of patients with interstitial lung diseases (I
Amgen adds BiTE to its cancer range as FDA clears Imdelltra
Amgen has doubled its range of bispecific T-cell engager (BiTE) drugs with the FDA approval of tarlatamab for advanced small cell lung cancer (SCLC) after a priority revie
J&J reels in bispecific specialist Proteologix in $850m deal
Johnson & Johnson has agreed a $850 million deal to acquire Proteologix that will give it a pair of early-stage bispecific antibodies with immunology applications, inc
AI-powered WhatsApp messaging cleared for NHS pilot
An artificial intelligence-driven WhatsApp messaging platform for scheduling cervical cancer screening appointments is being piloted in London to see if it can improve tak
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
3rd mRNA Process Development & Manufacturing Summit
Your Roadmap for mRNA Process Development & Manufacturing with Optimized Purification, Process Analytics & Enhanced Formulation to Improve Cost-Effectiveness & Scalability into
2nd mRNA Quality Control & Compliance Summit
The 2nd mRNA Quality Control & Compliance Summit 2024 returns this June 25-27 (Boston, MA), as the sole industry-centred forum dedicated to showcasing technical data and though
The 9th CAR-TCR Summit Returns to Boston!
The commercial success of cell therapies is continuing to grow!
Word Monster and the PM Society Join Forces to Elevate Medic...
The PM Society and Word Monster are joining forces in a new partnership focusing on raising standards and nurturing talent in the MedComms industry.
4th Next Generation Gene Therapy Vectors Summit 2024
Accelerate your capsid and payload design with the 4th Next Generation Gene Therapy Vectors Summit (June 12-14, Boston), the industry’s only hub for covering the latest advances and innovations in